Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. (1/353)

"Pathologic" fractures: should these be included in epidemiologic studies of osteoporotic fractures? (2/353)

Morphological changes of injected calcium phosphate cement in osteoporotic compressed vertebral bodies. (3/353)

Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study. (4/353)

Protective effect of total and supplemental vitamin C intake on the risk of hip fracture--a 17-year follow-up from the Framingham Osteoporosis Study. (5/353)

Baseline serum estradiol and fracture reduction during treatment with hormone therapy: the Women's Health Initiative randomized trial. (6/353)

Improvement of trochanteric bone quality in an osteoporosis model after short-term treatment with parathyroid hormone: a new mechanical test for trochanteric region of rat femur. (7/353)

Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover. (8/353)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10